Why the study?
Does Placental protein 13 (PP13) induce vasodilation in isolated uterine arteries from nonpregnant and mid-pregnant rats?
Does Placental protein 13 (PP13) induce vasodilation in isolated uterine arteries from nonpregnant and mid-pregnant rats?
PP13 induces significant vasodilation in rat uterine arteries via endothelial prostaglandin and NO pathways, suggesting potential therapeutic value for gestational diseases with insufficient uteroplacental blood flow or maternal hypertension.
Placental protein 13 (PP13) induces hypotension in rats. This study aims to evaluate PP13 effects on isolated uterine arteries from nonpregnant and mid-pregnant rats. Vessels were isolated, cannulated, and pressurized to 50 mmHg within an arteriograph, preconstricted and exposed to increasing PP13 concentrations (10−13–10−8 M). PP13 elicited 38–50% arterial vasodilation with half-maximum response (EC50) = 1 pM. The relaxation was mediated by activating the endothelial-signaling pathways of prostaglandin and nitric oxide (NO). Accordingly, these results encourage evaluation of PP13 as a possible therapy for gestational diseases characterized by insufficient uteroplacental blood flow and/or maternal hypertension.
No takes yet. Share an insight, caveat, or question.
Drobnjak et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: